Ross C. Puffer, David J. Daniels, Caterina Giannini, Mark A. Pichelmann, Peter S. Rose, Michelle J. Clarke
  1. Mayo Clinic, 200 1st St SW Rochester, MN 55905, Mayo Medical School, MN 55905, USA
  2. Department of Neurosurgery, Mayo Clinic, 200 1st St SW Rochester, MN 55905, USA
  3. Department of Anatomic Pathology, Mayo Clinic, 200 1st St SW Rochester, MN 55905, USA
  4. Department of Orthopedic Surgery, Mayo Clinic, 200 1st St SW Rochester, MN 55905, USA

Correspondence Address:
Michelle J. Clarke
Department of Neurosurgery, Mayo Clinic, 200 1st St SW Rochester, MN 55905, USA


© 2011 Puffer RC This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

How to cite this article: Puffer RC, Daniels DJ, Giannini C, Pichelmann MA, Rose PS, Clarke MJ. Synovial sarcoma of the spine: A report of three cases and review of the literature. Surg Neurol Int 21-Feb-2011;2:18

How to cite this URL: Puffer RC, Daniels DJ, Giannini C, Pichelmann MA, Rose PS, Clarke MJ. Synovial sarcoma of the spine: A report of three cases and review of the literature. Surg Neurol Int 21-Feb-2011;2:18. Available from:

Date of Submission

Date of Acceptance

Date of Web Publication


Background:Synovial sarcoma (SS) is a rare sarcoma with distinct morphologic and genetic features, which, despite its name, does not arise from synovium. While most SSs (>80%) arise in the deep soft tissue of the extremities, up to 5% of these tumors are encountered in the body axis including the spine, mediastinum, retroperitoneum, and head/neck regions. Reports of SS located within the spinal axis have been rare to date.

Materials and Methods:We searched the medical records at our institution and found three patients who were diagnosed and treated for SSs involving the spine. We also performed an exhaustive literature search using PubMed to identify all reported cases in the literature.

Results:In this study, we report on three SS cases involving the spine. All three cases involved the paraspinal muscles and spinal nerve roots, with one case having a significant leptomeningeal involvement. In two cases, “smaller operations” were performed first because the lesions were thought to be benign, however, when the final pathology identified them as SSs, more radical procedures were performed. Additionally, we identified 14 cases of SSs involving the spine published in the literature and all cases are reviewed here.

Conclusions:Due to limited numbers of cases, spine SS long-term outcomes are hard to quantify. The currently accepted standard of treatment for SSs starts with wide surgical excision with negative margins followed by chemotherapy and radiation. We summarize the available literature on spinal SSs and review the current treatment options available for these tumors.

Keywords: Case series review, Spinal synovial sarcoma, Treatment, Negative margins


Synovial sarcoma (SS) is a rare soft tissue tumor comprising 5–10% of soft tissue sarcomas and less than 1% of all malignancies.[ 6 7 16 30 ] SS affects mainly adolescents and young adults with a peak incidence in the third decade. Approximately, 30% of cases occur before the age of 20, and 90% before 50.[ 7 30 ] Despite its name, SS does not originate and/or differentiate toward synovium (less than 5% of cases arise from joints or bursa). Although SS can occur in any part of the body, more than 80% of tumors arise in the deep soft tissue of the extremities, especially around the knee. The etiology of SS is unknown but they appear to have an epithelial phenotype. Although it is known for being particularly aggressive, SS often grows slowly, forming a circumscribed, multinodular tumor without a capsule.[ 6 ] More than 90% of SS show a consistent, balanced reciprocal translocation t(X:18)(p11:q11) presumably relevant in its pathogenesis. This translocation involves the fusion of the SYT gene at 18q11 to either homologous genes SSX1 or SSX2 at Xp11.[ 6 9 14 25 30 33 ] This allows for several histopathological variants, including monophasic, biphasic and poorly differentiated forms.[ 6 14 33 ] Although there is no significant correlation among tumor location, metastases at time of diagnosis, age, sex, or the type of transcript, in patients with localized tumors, SYT-SSX2 fusion transcripts seem to predict significantly longer metastasis-free survival than SYT-SSX1 fusion transcripts.[ 14 ]

Surgical excision with wide, negative margins is the currently recommended treatment with adjuvant radiotherapy and/or doxorubicin-based chemotherapy.[ 19 ] While this is a mainstay of treatment, there is no consensus on the optimal treatment strategy. Local recurrence occurs in up to 50% of cases, usually within 2 years, although some studies have shown the 5 year local and distant recurrence rates to be 12% and 39%, respectively.[ 6 17 ] Lungs and bone are frequent sites of metastases, but regional lymph nodes can also be involved in 20% of cases.[ 6 17 ] Patients with favorable prognostic factors (calcifying variants and SSX2 involved fusions) have shown 10 year survival rates of 43–63%.[ 6 ]

Reports of SS arising from, near, or metastatic to the spine are rare and difficult to find in the journals. In this article, we present the experience at our institution with these cases and review the available literature.


We searched the patient and surgical pathology databases at our institution using the keywords synovial sarcoma, spine, paraspinal, cervical, thoracic, or lumbar and identified three patients diagnosed and treated for spinal SS since 2004. We also searched PubMed at using the same keywords and found 14 cases reported in the available literature.


Case 1: Thoracic Dumbbell SS

A 59-year-old woman presented with a two-year history of constant, progressively worsening, left-sided upper thoracic pain. In the month prior to presentation, she also experienced ascending paresthesias from her toes to the T5 dermatome along with gait weakness and instability. Imaging studies elsewhere revealed a dumbbell-shaped upper thoracic mass emanating from the T5 foramen with extensive encasement and compression of the thoracic cord from approximately T4 through T6. Additionally, the tumor appeared to extend into the T5 vertebral body. A CT-guided biopsy of the mass was performed and was diagnosed as a “spindle cell tumor consistent with schwannoma.” Since her symptoms continued to progress despite treatment with steroids and radiation, she was referred to our institution for further treatment including surgical resection.

Following a lengthy discussion, the patient chose to undergo partial resection of her lesion. The tumor was exposed through a T3-T6 laminectomy and an extensive epidural mass was noted dorsally between T4 and T5 and extending out the T4-5 foramen, infiltrating the T4-5 facets and encasing the T4 nerve root. The tumor was grossly debulked, and the final pathology report revealed a high-grade SS [ Figure 1 ]. The patient tolerated surgery well and there were no complications. Since the pathology showed a high-grade sarcoma, adjuvant therapy was planned to reduce her overall tumor burden before a second-staged surgical procedure. After she recovered from her surgery, the patient was started on three cycles of ifosfamide/adriamycin (7500 mg per sq. m/60 mg per sq. m, respectively) chemotherapy. She then returned home and received 46 Gy of total radiation to her tumor volume in addition to the previous 4 Gy received.

Figure 1

Case 1 (A–C) with low power (A) and high power (B) spindle cell appearance and focal epithelial membrane antigen immunoreactivity (C). Case 2 (D–F) illustrating the morphologic appearance of the paraspinal biopsy (D) and leptomeningeal infiltration (E). The RT-PCR (F) detects the chimeric fusion transcripts SYT-SSX2 using specific primers. Case 3 (G–J) Low power appearance (G) of the tumor with gaping vessels (so-called “hemangiopericytomatous vascular pattern”) and high power (H). The tumor expresses both epithelial membrane antigen (I) as well as cytokeratin (J) immunoreactivity


The adjuvant therapy had stabilized her disease and 7 months following her initial evaluation she underwent a second-staged operation. A one-piece gross total resection of T4, 5, 6, and 7 vertebra with a posterior instrumented spinal fusion from T1-L1 was performed. The tumor was removed with negative margins. The patient recovered well from the operation. She was seen on a 6-month basis by oncology with no recurrence of her tumor noted and improving symptoms. A year and a half later, she returned, complaining of new-onset back pain in her right scapular region and left mid back. This pain was found to be attributed to a fractured rod, which was surgically repaired. She continues to be followed and she has no evidence of tumor recurrence or metastases 67 months after the final resection.

Case 2: Paraspinal SS with Leptomeningeal Spread

A 54-year-old woman presented with several months of pain in her right buttock and hip, paresthesias of her right leg, and generalized right leg weakness. Her symptoms progressed, involving her left leg in a similar fashion and a sensory level at the costal margin was found bilaterally. Over the last month, she noted saddle numbness and loss of bladder and bowel control. Spine MR showed a large, right-sided, paraspinal mass centered around T10 with adjacent leptomeningeal enhancement—no spinal cord compression was noted [ Figure 2 ]. A CT-guided biopsy was consistent with a spindle cell tumor, but the specific tumor type was indeterminate.

Figure 2

Preoperative T1-sagittal MRI with contrast shows (A) a paraspinal mass extending through the foramen as well as (B) leptomeningeal spread


There was some question if the leptomeningeal enhancement was associated with the paraspinal mass or was an unrelated disease process. The location of maximum leptomeningeal enhancement was at the T12-L1 junction. A T12-L1 laminectomy was performed and the underlying thickened arachnoid was biopsied. The leptomeninges demonstrated the presence of a spindle cell tumor similar in morphology to the one seen in the epidural CT-guided biopsy. The tumor cell morphology suggested the diagnosis of monophasic SS, a diagnosis confirmed by immunohistochemical and RT-PCR studies [ Figure 1 ]. The tumor arose from a paraspinal mass and extended through the dura to the leptomeninges, a very unusual presentation for SS. There were no metastatic findings at that time and systemic chemotherapy (ifosfamide and doxorubicin) was recommended. The patient returned home to receive treatment at another institution. We learned through correspondence with her home institution that the patient died 4 months later most likely from a right-midbrain lesion that appeared consistent with a glioma on MR imaging studies. No autopsy was performed.

Case 3: T5-6 Paraspinal SS

This 32-year-old woman presented with 8 years of progressive right-sided subscapular thoracic pain incited by lifting her arm above her head. This pain became more frequent and began to occur spontaneously, disrupting her sleep and causing her significant difficulties. Two MRI studies were performed during this time, the first in 2004 and the second in 2009, and she was told that the findings were unremarkable. When she presented to our institution, she had severe, mechanically reproducible pain located several inches to the right of her mid-thoracic spine. The pain also radiated both up to the axilla as well as down the right leg. A review of outside MRI studies revealed a lobulated, T1 isointense, mildly T2 hyperintense, 3 cm enhancing mass involving the right T5 nerve root through the foramen with extension into the paraspinal muscles [ Figure 3 ]. These imaging characteristics were most consistent with a schwannoma or another nerve sheath tumor since there was little change on interval exams that were 5 years apart.

Figure 3

Preoperative T1-axial MRI with contrast shows an enhancing paraspinal mass with foraminal extension


As it was felt that this symptomatic lesion was likely benign and easily accessible, resection was advised. Intraoperatively, the mass was identified in the erector spinae muscles of the T4-7 region on the right side. The tumor was mobilized and gross total resection achieved, including the foraminal component. However, intraoperative pathology revealed a spindle cell sarcoma rather than a benign process, necessitating extension of the surgical resection. A T5-6 laminectomy was then performed, the dura incised, and the entire nerve root in the foramen of presumed origin was resected until negative dural margins were achieved. After the dural closure, all grossly visible tumor appeared to have been removed from the region and surrounding tissues. Final pathology showed a high-grade, fibrous-type, monophasic SS. The patient tolerated the surgery well and was neurologically intact.

Concern for residual tumor remained as postoperative imaging studies demonstrated abnormal T5-6 transverse processes. To achieve a complete resection with negative margins a second surgery was undertaken where a one-piece gross total resection was performed of the entire tumor bed. Both transverse processes were resected and gross residual tumor was found in the T6 transverse process. Wide margins were excised, and the pathologist entered the OR to correlate the negative margins with the visualization of the previous tumor bed. Based on these findings, it appeared that the resection had removed all residual viable tumor present. The patient tolerated the second operation well.

At 6-month follow-up, no local tumor recurrence was found, but several small lung nodules were noted on chest CT. These nodules were consistent with metastases and the largest was measured at 7 mm. She was seen in oncology and systemic chemotherapy to shrink the tumors and resection of these nodules has been planned. At 1-year follow-up, her spine continues to be disease free, while her lung nodules have slightly increased in size. Therapy is ongoing at this time to address the lung nodules.


SS is a rare, aggressive neoplasm of uncertain origin predominantly affecting adolescents and young adults.[ 6 30 ] It is associated with a balanced reciprocal translocation t(X:18)(p11:q11). SS presents in a variety of histopathological forms, from monophasic, being uniformly comprised of spindle cells, to biphasic, with epithelial and spindle cell components.[ 6 9 14 25 30 33 ] Due to histological variety, SS can be mistaken for numerous other mesenchymal or nonmesenchymal tumors, making immunohistochemical and molecular studies important in achieving the correct diagnosis.[ 13 ]

Definitive characteristics making SS completely distinguishable on radiologic examination have not been seen, making diagnosis difficult.[ 20 ] Plain radiographs may be normal in up to 50% of patients with SS, making it difficult to visualize unless the tumor is eroding adjacent bony structures. However, tumor calcification may be seen in approximately 30% of patients and these calcifications become readily apparent on routine radiography or computerized tomography.[ 29 ] On CT imaging, SS may appear as a well demarcated, hypodense mass with homogenously or heterogeneously enhancement, making it easy to confuse with other benign or malignant tumors.[ 20 ] MRI has proven to be the superior modality for detecting SS. In cases localized to the head and neck, it has been shown that these tumors possess a signal intensity similar to fat on T2-weighted images, and isointense as compared to gray matter on T1-weighted images.[ 11 ]

It is widely accepted that the current most effective treatment for SS is a wide surgical excision with negative margins.[ 6 13 19 ] Use of adjuvant radiation therapy decreases the local recurrence rate.[ 1 ] Radiation proved to be superior to chemotherapy alone as adjuvant therapy to primary surgical excision.[ 10 ] A single chemotherapy protocol has not yet been proven most effective in treating SS, but two agents, doxorubicin and ifosfamide have demonstrated meaningful activity in the treatment of soft tissue sarcomas.[ 19 ] Specifically, high dose ifosfamide has been associated with improved disease-specific survival in adult patients with high-risk primary SS and should be considered a standard part of the chemotherapy regimen for this disease.[ 5 23 ]

Most of the available information on SS has come from tumors localized to the extremities. However, up to 5% of these tumors are encountered in the body axis, including the spine, mediastinum, retroperitoneum, and head and neck region. Reports of SS located within the spinal axis have been rare and are limited to 13 case reports on 14 patients published in the literature [ Table 1 ]. Of these 14 patients with spinal SS, 8 were within the paraspinal musculature (with most having foraminal extension), 3 were intradural and associated with spinal nerve roots, 2 were metastatic lesions (one to bone, the other intramedullary), and 1 was a bony/lytic lesion. The cases we present here all involved the paraspinal muscles with two of them being associated with spinal nerve roots, the other having significant leptomeningeal extension, this finding not previously reported in the literature.

Clinical differential diagnosis for SS involving the spine includes primarily nerve sheath tumors, and most SS are assumed to be benign nerve sheath tumors preoperatively. Indeed, in two of our cases a simpler/smaller operation was performed first because the lesions were thought to be benign, however, when the final pathology identified SS, a larger more radical procedure was performed. With this limited data, the long-term outcomes are hard to quantitate for SS involving the spine. Based on the previous case reports, most patients died within 3 years following diagnosis, with the exception of a 14-year-old girl who remained disease-free at 6 years.[ 3 ]

Over half of the reported spinal SS had dumbbell-shaped intraforaminal extension with a larger extraspinal and smaller intraspinal component. In most cases, the patients’ symptoms were caused by the intraspinal component and resultant compression of neural elements. It was striking however, how large the extraspinal portion was in many of the cases. The most common tumor presenting in this fashion is a benign schwannoma, whereas, malignant nerve sheath tumors are very rare. In regards to SS, it is the rapid growth of the extraspinal portion that is most suggestive of a malignant process. However, in one of our cases, the patient had serial MRI scans 5 years apart and there was minimal growth during this time, which is most unusual for a sarcoma.

Some of these unique properties of SS are just now being understood at a molecular level. It has been recently reported that microRNAs (miRNAs) may play an expanded role in the tumorigenesis of some cancers, and when deregulated, depending on their mRNA targets, they can act to down regulate tumor suppressor genes and give a growth advantage to tumor cell lines.[ 4 ] In SS, a unique pattern of deregulated miRNAs has been found that is distinct from muscle tissue and a wide range of other sarcoma types.[ 12 ] Specifically, the overexpression of a microRNA, miR-183, has been found to act as an oncogene through down regulation of EGR1 translation, a tumor suppressor that is correlated strongly with tumor formation and transformation processes when its levels are depleted.[ 26 ] Another overexpressed miRNA, let-7e, has been shown to down regulate expression of HMGA2, a transcription factor which works in concert with the SS18-SSX fusion product to decrease levels of SNAI1, a transcriptional repressor, ultimately causing epithelial differentiation and transition in SS.[ 12 ] Importantly, when let-7e was inhibited by a miRNA inhibitor, the proliferation of the SS cells were suppressed. While these findings are very new, they provide a better understanding of the underlying molecular basis for SS tumorigenesis and also present possible future targets for pharmacological therapies.

Experts agree that the cornerstone of treatment for SS is wide surgical excisions with negative margins. Based on our experience, if a spinal dumbbell tumor has any characteristic that would be unusual for a benign nerve sheath tumor, a needle-guided biopsy should be performed first to obtain a diagnosis. Ideally, this is followed by a definitive operation to try and remove the tumor en bloc with negative margins. Traditionally, a 5 cm margin defines a negative margin in sarcoma surgery, however, in many of these cases this would encompass critical structures such as the spinal cord. Thus, in many cases, the best that can be hoped for is a gross total resection with “marginal margins” in which there is no pathologic specimen, but critical structures are not injured.


SS of the spine can be challenging to diagnose and even harder to treat. Best available evidence suggests that a multimodal treatment strategy starting with aggressive surgical resection followed by radiation and chemotherapy offers the patients the best chance for a cure. The underlying molecular genetics for SS tumorigenesis is just now being elucidated and hopefully will lead to a better understanding in regards to tumor pathology and lead to novel therapeutics in the future.


1. Alektiar KM, Leung D, Zelefsky MJ, Brennan MF. Adjuvant radiation for stage II-B soft tissue sarcoma of the extremity. J Clin Oncol. 2002. 20: 1643-50

2. Arnold PM, Roh S, Ha TM, Anderson KK. Metastatic synovial sarcoma with cervical spinal cord compression treated with posterior ventral resection: Case report. J Spinal Cord Med. 2010. 33: 80-4

3. Barus CE, Monsey RD, Kalof AN. Poorly differentiated synovial sarcoma of the lumbar spine in a fourteen-year-old girl. A case report. J Bone Joint Surg Am. 2009. 91: 1471-6

4. Calin GA, Groce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006. 6: 857-66

5. Eilber FC, Brennan MF, Eilber FR, Eckardt JJ, Grobmyer SR, Riedel E. Chemotherapy is associated with improved survival in adult patients with primary extremity synovial sarcoma. Ann Surg. 2007. 246: 105-13

6. Fisher C. Synovial sarcoma. Ann Diagn Pathol. 1998. 2: 401-21

7. Fisher C, deBruijn DR, Geurts van Kessel A, Fletcher CD, Unni KK, Mertens F.editors. Synovial sarcoma. Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon: IARC Press; 2002. p. 200-4

8. Greene S, Hawkins DS, Rutledge JC, Tsuchiya KD, Douglas J, Ellenbogen RG. Pediatric intradural extramedullary synovial sarcoma: Case report. Neurosurgery. 2006. 59: E1339-

9. Halder M, Randall RL, Capecchi MR. Synovial sarcoma: From genetics to genetic-based animal modeling. Clin Orthop Relat Res. 2008. 466: 2156-67

10. Harb WJ, Luna MA, Patel SR, Ballo MT, Roberts DB, Sturgis EM. Survival in patients with synovial sarcoma of the head and neck: Association with tumor location, size, and extension. Head Neck. 2007. 29: 731-40

11. Hirsch RJ, Yousem DM, Loevner LA, Montone KT, Chalian AA, Hayden RE. Synovial sarcomas of the head and neck: MR findings. AJR Am J Roentgenol. 1997. 169: 1185-8

12. Hisaoka M, Matsuyama A, Nagao Y, Luan L, Kuroda T, Akiyama H. Identification of altered microRNA expression patterns in synovial sarcoma. Genes Chromosomes Cancer. 2011. 50: 137-45

13. Jang JW, Lee JK, Seo BR, Kim SH. Synovial sarcoma of the posterior neck: A case report and review of literature. J Korean Neurosurg Soc. 2010. 47: 306-9

14. Kawai A, Woodruff J, Healey JH, Brennan MF, Antonescu CR, Ladanyi M. SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma. N Engl J Med. 1998. 338: 153-60

15. Koehler SM, Beasley MB, Chin CS, Wittig JC, Hecht AC, Qureshi SA. Synovial sarcoma of the thoracic spine. Spine J. 2009. 9: e1-6

16. Kransdorf MJ. Malignant soft tissue tumors in a large referral population: Distribution of diagnoses by age, sex and location. AJR Am J Roentgenol. 1995. 159: 575-9

17. Lewis JJ, Antonescu CR, Leung DH, Blumberg D, Healey JH, Woodruff JM. Synovial sarcoma: A multivariate analysis of prognostic factors in 112 patients with primary localized tumors of the extremity. J Clin Oncol. 2000. 18: 2087-94

18. Morrison C, Wakely PE, Ashman CJ, Lemley D, Theil K. Cystic synovial sarcoma. Ann Diagn Pathol. 2001. 5: 48-56

19. Randall RL, Schabel KL, Hitchcock Y, Joyner DE, Albritton KH. Diagnosis and management of synovial sarcoma. Curr Treat Options Oncol. 2005. 6: 449-59

20. Rangheard AS, Vanel D, Viala J, Schwaab G, Casiraghi O, Sigal R. Synovial sarcomas of the head and neck: CT and MR imaging findings of eight patients. AJNR Am J Neuroradiol. 2001. 22: 851-7

21. Ravnik J, Potrc S, Kavalar R, Ravnik M, Zakotnik B, Bunc G. Dumbbell synovial sarcoma of the thoracolumbar spine: A case report. Spine (Phila Pa 1976). 2009. 34: E363-6

22. de Ribaupierre S, Vernet O, Beck-Popovic M, Meagher-Villemure K, Rilliet B. Cervical nerve root synovial sarcoma in a child with chromosomal (X;18) translocation. Case report and review of the literature. Pediatr Neurosurg. 2007. 43: 382-5

23. Rosen G, Forscher C, Lowenbraun S, Eilber F, Eckardt J, Holmes C. Synovial sarcoma. Uniform response of metastases to high dose ifosfamide. Cancer. 1994. 73: 2506-11

24. Sakellaridis N, Mahera H, Pomonis S. Hemangiopericytoma-like synovial sarcoma of the lumbar spine. Case report. J Neurosurg Spine. 2006. 4: 179-82

25. dos Santos NR, de Bruijn DR, van Kessel AG. Molecular mechanisms underlying human synovial sarcoma development. Genes Chromosomes Cancer. 2001. 30: 1-14

26. Sarver AL, Li L, Subramanian S. MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration. Cancer Res. 2010. 70: 9570-80

27. Scollato A, Buccoliero AM, Di Rita A, Gallina P, Di Lorenzo N. Intramedullary spinal cord metastasis from synovial sarcoma. Case illustration. J Neurosurg Spine. 2008. 8: 400-

28. Signorini GC, Pinna G, Freschini A, Bontempini L, Dalle Ore G. Synovial sarcoma of the thoracic spine. A case report. Spine (Phila Pa 1976). 1986. 11: 629-31

29. Suh SI, Seol HY, Hong SJ, Kim JH, Kim JH, Lee JH. Spinal epidural synovial sarcoma: A case of homogeneous enhancing large paravertebral mass on MR imaging. AJNR Am J Neuroradiol. 2005. 26: 2402-5

30. Sultan I, Rodriguez-Galindo C, Saab R, Yasir S, Casanova M, Ferrari A. Comparing children and adults with synovial sarcoma in the Surveillance, Epidemiology, and End Results program, 1983 to 2005: An analysis of 1268 patients. Cancer. 2009. 115: 3537-47

31. Treu EB, de Slegte RG, Golding RP, Sperber M, van Zanten TE, Valk J. CT findings in paravertebral synovial sarcoma. J Comput Assist Tomogr. 1986. 10: 460-2

32. Wu JW, Kahn SJ, Chew FS. Paraspinal synovial sarcoma. AJR Am J Roentgenol. 2000. 174: 410-

33. Yano M, Toyooka S, Tsukuda K, Dote H, Morimoto Y, Ohata N. SYT-SSX fusion genes in synovial sarcoma of the thorax. Lung Cancer. 2004. 44: 391-7

Leave a Reply

Your email address will not be published. Required fields are marked *